Table 3 Skin fibroblasts-based peripheral diagnosis of healthy control cases (N = 27).
From: Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients
Healthy control cases—Banked coriell samples | ||||||
|---|---|---|---|---|---|---|
Number | Sample ID | Ln(A/N) | MI Diagnosis | Age | Gender | Original diagnosis |
1 | AG09977* | 4.21 | Non-AD | 63 | F | Healthy control |
2 | AG11730* | 4.36 | Non-AD | 84 | M | Healthy control |
3 | AG12927* | 4.36 | Non-AD | 66 | F | Healthy control |
4 | AG12998* | 4.46 | Non-AD | 65 | M | Healthy control |
5 | AG04146* | 4.75 | Non-AD | 57 | M | Healthy control |
6 | AG07123* | 5.05 | Non-AD | 62 | M | Healthy control |
7 | AG13358* | 5.08 | Non-AD | 72 | F | Healthy control |
8 | AG04461* | 5.09 | Non-AD | 66 | M | Healthy control |
9 | AG07714* | 5.22 | Non-AD | 56 | F | Healthy control |
10 | AG12438* | 5.55 | Non-AD | 77 | M | Healthy control |
11 | AG05840* | 6.66 | Non-AD | 56 | F | Healthy control |
12 | 37** | 5.81 | Non-AD | 65 | F | Healthy control |
13 | 39** | 7.13 | Non-AD | 65 | F | Healthy control |
14 | 50** | 6.70 | Non-AD | 61 | M | Healthy control |
15 | 51** | 4.71 | Non-AD | 55 | M | Healthy control |
16 | 19** | 6.71 | Non-AD | 33 | M | Healthy control |
17 | 25** | 6.05 | Non-AD | 39 | M | Healthy control |
18 | 29** | 6.62 | Non-AD | 21 | M | Healthy control |
19 | 32** | 6.69 | Non-AD | 23 | M | Healthy control |
20 | 36** | 6.41 | Non-AD | 46 | M | Healthy control |
21 | 44** | 6.75 | Non-AD | 50 | F | Healthy control |
22 | 73** | 6.24 | Non-AD | 20 | F | Healthy control |
23 | 77** | 5.81 | Non-AD | 18 | M | Healthy control |
24 | 78** | 6.23 | Non-AD | 45 | F | Healthy control |
25 | 82** | 6.52 | Non-AD | 45 | F | Healthy control |
26 | 83** | 6.58 | Non-AD | 20 | M | Healthy control |
27 | 84** | 6.45 | Non-AD | 21 | M | Healthy control |